Aktie A14X6S CHAMPIONS ONCOLOGY, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Champions Oncology, Inc.

Aktien

A14X6S

US15870P3073

CSBR

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:00 01.05.2024 		% 5 Tage % 1. Jan.
4,86 USD +0,21 % Intraday Chart für Champions Oncology, Inc. -3,38 % -13,52 %
13.03. CHAMPIONS ONCOLOGY, INC. : Craig-Hallum senkt seine Meinung und wechselt zu Neutral ZM
12.03. Champions Oncology, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Januar 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
MORNING BID AMERICAS-Disinflation station
North American Morning Briefing : Traders Eye -2-
Champions Oncology, Inc.
Champions Oncology Announces the Addition of Brady Davis as President
Champions Oncology, Inc. Appoints Brady Davis as President
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
Champions Oncology : Reports Quarterly Revenue of $12.6 Million - Form 8-K
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
Champions Oncology Enters Multiyear Deal With BioVolume to Better Evaluate Cancer Studies
Champions Oncology, Inc. Announces Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
Champions Oncology, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023
Champions Oncology, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2023
Champions Oncology Forms Therapeutic Discovery Platform Unit Corellia AI
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14X6S Aktie
  4. Nachrichten Champions Oncology, Inc.
  5. Andere Sprachen